Amina Džidić-Krivić’s Post

Dear Linked team, I am so proud to share that the novel research article by my amazing ISEST team was published today. It is entitled: "Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy" – A review in Diabetes & Metabolic Syndrome: Clinical Research & Reviews Journal. Big congratulations to my hard-working team, and especially Emina K. Sher MPharm, PhD, who was the heart of this project. 🎉🌸 • Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews • *Journal Impact Factor: 10* • H-Index: 71 • *Journal Rating: Q1* • Publisher: Elsevier – Netherlands • Publication Date: 5 November 2023 Neuropathy is among the most often reported consequences of diabetes and the biggest cause of morbidity and mortality in people suffering from this life-long disease. There are various traditional drugs and non-pharmacological methods used to treat this health condition. However, the research in the area of pathogenic-oriented drugs in the treatment of DN showed no recent breakthroughs, mostly due to the limited evidence about their effectiveness and safety obtained through clinical trials. Consequently, there is an urgent demand for the development of novel therapeutic options for diabetic neuropathy. Some of the latest novel diagnostic methods for diagnosing diabetic neuropathy are discussed as well as the new therapeutic approaches, such as the fusion of neuronal cells with stem cells, targeting gene delivery and novel drugs. #diabetes #neuropathy #neurology #imunology #stemcells #inflammation #geneticengineering Feel free to read, share and recommend our new article via provided link: https://lnkd.in/efQT2dPM